- Home
- FRPH vs SLDB Comparison
FRPH vs SLDB Comparison
Compare FRPH & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRPH
- SLDB
- Stock Information
- Founded
- FRPH 1986
- SLDB 2013
- Country
- FRPH United States
- SLDB United States
- Employees
- FRPH N/A
- SLDB N/A
- Industry
- FRPH Real Estate
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FRPH Finance
- SLDB Health Care
- Exchange
- FRPH Nasdaq
- SLDB Nasdaq
- Market Cap
- FRPH 482.5M
- SLDB 478.9M
- IPO Year
- FRPH N/A
- SLDB 2018
- Fundamental
- Price
- FRPH $24.21
- SLDB $5.62
- Analyst Decision
- FRPH
- SLDB Strong Buy
- Analyst Count
- FRPH 0
- SLDB 10
- Target Price
- FRPH N/A
- SLDB $15.00
- AVG Volume (30 Days)
- FRPH 59.4K
- SLDB 1.2M
- Earning Date
- FRPH 11-05-2025
- SLDB 11-05-2025
- Dividend Yield
- FRPH N/A
- SLDB N/A
- EPS Growth
- FRPH N/A
- SLDB N/A
- EPS
- FRPH 0.28
- SLDB N/A
- Revenue
- FRPH $32,293,999.00
- SLDB N/A
- Revenue This Year
- FRPH N/A
- SLDB N/A
- Revenue Next Year
- FRPH N/A
- SLDB N/A
- P/E Ratio
- FRPH $86.44
- SLDB N/A
- Revenue Growth
- FRPH 3.18
- SLDB N/A
- 52 Week Low
- FRPH $23.52
- SLDB $2.41
- 52 Week High
- FRPH $33.00
- SLDB $7.37
- Technical
- Relative Strength Index (RSI)
- FRPH 39.29
- SLDB 48.05
- Support Level
- FRPH $23.52
- SLDB $5.71
- Resistance Level
- FRPH $24.48
- SLDB $6.36
- Average True Range (ATR)
- FRPH 0.49
- SLDB 0.42
- MACD
- FRPH -0.01
- SLDB 0.03
- Stochastic Oscillator
- FRPH 35.03
- SLDB 43.07
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.